Liberty All-Star Growth Fund, Inc. reports recurring closed-end fund updates for its NYSE-listed shares under the symbol ASG. The fund seeks long-term capital appreciation through a diversified equity portfolio and uses a multi-manager growth strategy with distinct small-, mid- and large-capitalization mandates selected and monitored by its investment advisor.
Company news commonly covers monthly net asset value, market price and discount data, total-return performance, sector allocation across areas such as information technology, industrials, health care and consumer discretionary, quarterly distribution declarations, dividend reinvestment mechanics and investment manager changes within the fund's growth portfolio structure.
The Liberty All-Star Growth Fund (NYSE: ASG) published its July 2020 monthly update. The fund employs an all-cap growth strategy through three managers focusing on small-, mid-, and large-cap investments. As of July 31, 2020, total net assets were $281.8 million, with 99.9% invested in equities. The fund’s NAV increased by 6.32% for the month, while the market price rose by 15.37%. The top holdings included Chegg, Inc. and Microsoft Corp., and the portfolio emphasized Information Technology (31.8%) and Health Care (25.1%). Recent changes include new positions in Neurocrine Biosciences, Inc. and Vertex, Inc.
Liberty All-Star Growth Fund (NYSE: ASG) released its monthly update for June 2020, highlighting a significant increase in NAV to $6.49, a 3.18% monthly performance. The fund's total net assets reached $270.1 million, with equities valued at $264.5 million, representing a 97.9% investment rate. The fund's top sectors include Information Technology (32.7%) and Health Care (24.6%). New investment holdings included Core Laboratories and Horizon Therapeutics. The fund remains focused on all-cap growth strategies through diverse investment managers.
The Liberty All-Star Growth Fund (NYSE: ASG) reported its May 2020 Monthly Update, highlighting a net asset value (NAV) increase to $6.29 from $5.68 at the beginning of the month, reflecting a performance gain of 10.74%. The fund's market price rose to $5.96, showing a 5.2% discount. The total net assets stood at $260.6 million, with equities valued at $258.5 million, and a 99.2% investment rate. Key holdings included Paylocity, FirstService, and Nevro Corp.